RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Ori Biotech

Ori Biotech

Ori Biotech develops the IRO platform for cell and gene therapy manufacturing.

Latest funding

$100M Series B+ ·

Led by Chimera Investment · Source: fundraisingfox.com

All 2 rounds ↓
Website: oribiotech.com.
X: @OriBiotech · 515 followers.
LinkedIn: oribiotech-ltd.
Sectors: Biotechnology, Industrial Automation, Manufacturing, Therapeutics.
Stage: Series B+.
Based in: London, United Kingdom.
Founded: 2015.
Last round: Jan 18, 2022 · 1,763 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

X account@OriBiotech · created Dec 20, 2019 (6 years old) · 515 followers
Website registeredAug 27, 2015 (11 years old)
About Ori Biotech

This platform provides flexible tools for scientists to streamline development and automate processes. Ori Biotech aims to enable widespread patient access to cell and gene therapies.

TIMELINE · MONEY RAISED

Ori Biotech | 20 days from X account to first raise on record

@OriBiotech·Raised $100M in 1 sourced round·1 signal before the first raise
$25M$50M$75M$100MJAN 2020DECNOVOCTSEPAUGJULJUN$100M||X ACCOUNT CREATED @ORIBIOTECH · DEC 20, 2019Seed · Jan 9, 2020SEED · JAN '20$100M Series B+ · Jan 18, 2022$100M B+ · JAN '22

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$100MCChimera Investmentfundraisingfox.com
SeedundisclosedDDelin Venturesprnewswire.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like Ori Biotech

Other companies backed by Chimera Investment

Chimera Investment portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ori-biotech (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy